The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy-Reference-Cited by-同舟云学术

The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy

Published:2014-11-06 Issue:3 Volume:36 Page:1519-1527
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Tampellini M.,Ottone A.,Alabiso I.,Baratelli C.,Forti L.,Berruti A.,Aroasio E.,Scagliotti G. V.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2693-3.pdf

Reference22 articles.

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69.

2. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Investig. 2005;23(4):338–51.

3. Al-Sarraf M, Baker L, Talley RW, et al. The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. Cancer. 1979;44(4):1222–55.

4. De Gramont A, Krulic M, Kadi J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer. Eur J Cancer Clin Oncol. 1988;24(9):1499–503.

5. Barone C, Astone A, Cassano A, et al. Advanced colon cancer: staging and prognosis by CEA test. Oncology. 1990;47(2):128–32.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rectum to Medulla Oblongata: Colorectal Cancer Metastasizing to the Brainstem;Cureus;2023-05-30

2. Consensus molecular subtyping improves the clinical usefulness of canonical tumor markers for colorectal cancer;Biomedical Research;2022-12-01

3. Primary Tumor Resection Provides Survival Benefits for Patients with Synchronous Brain Metastases from Colorectal Cancer;Diagnostics;2022-06-29

4. Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer;Journal of Gastrointestinal Oncology;2020-12

5. Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study;Scientific Reports;2020-04-08